Loading…
Loading…
OPK.TA does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for OPK.TA and 80,000+ other tickers.
See exactly how OPK.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OPK.TA and 80,000+ other tickers.
OPKO Health, Inc. is a global healthcare enterprise operating across the diagnostics and pharmaceutical sectors. Its reach extends across the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. Within its Diagnostics segment, the company notably operates BioReference Laboratories, a provider of comprehensive laboratory testing services. These services are crucial for the identification, diagnosis, assessment, monitoring, and management of various diseases. The offerings span specialized areas like esoteric testing, molecular diagnostics, anatomical…
No recent news available.